• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣植入术后冠状动脉造影及经皮冠状动脉介入术的复杂性评估及技术方面。

Complexity assessment and technical aspect of coronary angiogram and percutaneous coronary intervention following transcatheter aortic valve implantation.

机构信息

Cardiology Division of the University Hospital of Geneva, Switzerland.

出版信息

Cardiol J. 2022;29(2):197-204. doi: 10.5603/CJ.a2020.0073. Epub 2020 May 21.

DOI:10.5603/CJ.a2020.0073
PMID:32436588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9007485/
Abstract

BACKGROUND

Performing selective coronary angiogram (CA) and percutaneous coronary intervention (PCI) post transcatheter aortic valve implantation (TAVI) may be challenging with various success rates of coronary ostia engagement.

METHODS

Among all patients who underwent CA and/or PCI after TAVI from our single center TAVI registry, ostia cannulation success was reported according to the quality of ostia engagement and artery opacification, and was classified as either selective, partially selective or non-selective but sufficient for diagnosis.

RESULTS

Among the 424 consecutive TAVI procedures performed at the aforementioned institution, 20 (4.7%) CA were performed in 19 (4.5%) patients at a median time of 464 days post TAVI (25-75% IQ: 213-634 days). CA were performed in 7 CoreValve, 9 Evolut R, 1 Evolut PRO and 2 Edwards Sapien 3 devices. Transradial vascular approach was attempted in 9 procedures (45%, right n = 6 and left n = 3) and was successful in 8 (40%) patients. A total of 20 left main artery ostium cannulation were attempted leading to a diagnostic CA in all of them with selective engagement in 65%. Engagement of the right coronary artery in 2 out of 15 attempted cases failed due to a low ostium in conjunction with a high implantation of a CoreValve prosthesis. 11 PCI (55% of CA) including 2 left main lesions were performed. In 4 patients (36.4% of the PCI), an extension catheter was required to engage the left main. All planned PCI were successful.

CONCLUSIONS

Post TAVI CA and PCI are challenging but feasible even after supra-annular self-expandable valve implantation.

摘要

背景

经导管主动脉瓣置换术(TAVI)后行选择性冠状动脉造影(CA)和经皮冠状动脉介入治疗(PCI)可能具有挑战性,因为冠状动脉口的吻合成功率各不相同。

方法

在我们的单中心 TAVI 注册中心,所有 TAVI 后行 CA 和/或 PCI 的患者中,根据冠状动脉口吻合质量和动脉显影情况报告了冠状动脉口插管成功率,并分为选择性、部分选择性或非选择性但足以诊断。

结果

在上述机构进行的 424 例连续 TAVI 手术中,19 例(4.5%)患者在 TAVI 后中位时间 464 天(25-75% IQ:213-634 天)内行 20 次 CA(4.7%)。CA 在 7 例 CoreValve、9 例 Evolut R、1 例 Evolut PRO 和 2 例 Edwards Sapien 3 装置中进行。9 例(45%,右 n = 6,左 n = 3)尝试经桡动脉血管入路,8 例(40%)成功。总共尝试了 20 次左主干动脉口插管,所有尝试均获得了诊断性 CA,选择性吻合率为 65%。在 15 例尝试中,有 2 例右冠状动脉未能吻合,原因是冠状动脉口较低,同时 CoreValve 假体植入较高。进行了 11 次 PCI(CA 的 55%),其中包括 2 例左主干病变。在 4 例患者(PCI 的 36.4%)中,需要使用扩张导管才能吻合左主干。所有计划的 PCI 均成功。

结论

TAVI 后 CA 和 PCI 具有挑战性,但即使在瓣上自膨式瓣膜植入后也可行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0cc/9007485/d91400956778/cardj-29-2-197f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0cc/9007485/d91400956778/cardj-29-2-197f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0cc/9007485/d91400956778/cardj-29-2-197f1.jpg

相似文献

1
Complexity assessment and technical aspect of coronary angiogram and percutaneous coronary intervention following transcatheter aortic valve implantation.经导管主动脉瓣植入术后冠状动脉造影及经皮冠状动脉介入术的复杂性评估及技术方面。
Cardiol J. 2022;29(2):197-204. doi: 10.5603/CJ.a2020.0073. Epub 2020 May 21.
2
Coronary Access After TAVR.经 TAVR 后的冠状动脉通路。
JACC Cardiovasc Interv. 2020 Mar 23;13(6):693-705. doi: 10.1016/j.jcin.2020.01.216.
3
Coronary Access and Percutaneous Coronary Intervention Up to 3 Years After Transcatheter Aortic Valve Implantation With a Balloon-Expandable Valve.经皮球囊扩张式主动脉瓣置换术后 3 年内的冠状动脉入路和经皮冠状动脉介入治疗。
Circ Cardiovasc Interv. 2020 Jul;13(7):e008972. doi: 10.1161/CIRCINTERVENTIONS.120.008972. Epub 2020 Jun 25.
4
Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement with medtronic self-expanding prosthesis: Insights from correlations with computer tomography.经导管主动脉瓣置换术使用美敦力自膨胀式假体后的冠状动脉造影和经皮冠状动脉介入治疗:与计算机断层扫描相关性的见解
Int J Cardiol. 2020 Oct 15;317:18-24. doi: 10.1016/j.ijcard.2020.05.065. Epub 2020 Jun 1.
5
Incidence, Technical Safety, and Feasibility of Coronary Angiography and Intervention Following Self-expanding Transcatheter Aortic Valve Replacement.自膨胀经导管主动脉瓣置换术后冠状动脉造影及介入治疗的发生率、技术安全性和可行性
Cardiovasc Revasc Med. 2019 May;20(5):371-375. doi: 10.1016/j.carrev.2019.01.026. Epub 2019 Feb 14.
6
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术后的冠状动脉导管插入术和经皮介入治疗
Am J Cardiol. 2017 Aug 15;120(4):625-631. doi: 10.1016/j.amjcard.2016.10.046. Epub 2016 Nov 16.
7
Incidence and feasibility of coronary access after transcatheter aortic valve replacement.经导管主动脉瓣置换术后冠状动脉入路的发生率和可行性。
Catheter Cardiovasc Interv. 2020 Nov;96(5):E535-E541. doi: 10.1002/ccd.28720. Epub 2020 Jan 8.
8
Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self-expandable bioprosthetic valve.使用美敦力™自膨胀生物瓣膜进行经导管主动脉瓣置换术后冠状动脉造影和经皮冠状动脉介入治疗的可行性
Catheter Cardiovasc Interv. 2018 Jun;91(7):1339-1344. doi: 10.1002/ccd.27346. Epub 2017 Oct 8.
9
Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience.经导管主动脉瓣植入自膨胀式人工瓣膜后经皮冠状动脉介入治疗的发生率、可行性及结果。单中心经验结果
Cardiovasc Revasc Med. 2016 Sep;17(6):391-8. doi: 10.1016/j.carrev.2016.05.010. Epub 2016 Jun 17.
10
Challenges of coronary angiography and intervention in patients previously treated by TAVI.经 TAVI 治疗的患者行冠状动脉造影和介入治疗的挑战。
Clin Res Cardiol. 2015 Aug;104(8):632-9. doi: 10.1007/s00392-015-0824-5. Epub 2015 Feb 27.

引用本文的文献

1
Operation in the gray zone: is SAVR still useful in patients aged between 75 and 80 years?灰色地带的手术:75至80岁患者行外科主动脉瓣置换术是否仍有价值?
Future Cardiol. 2024 Dec-Dec;20(15-16):849-858. doi: 10.1080/14796678.2024.2433827. Epub 2024 Nov 25.
2
A case report of virtual reality-guided percutaneous coronary intervention for anomalous origin of right coronary artery chronic total occlusion.虚拟现实引导下经皮冠状动脉介入治疗右冠状动脉慢性完全闭塞异常起源的病例报告。
Eur Heart J Case Rep. 2023 Oct 11;7(10):ytad507. doi: 10.1093/ehjcr/ytad507. eCollection 2023 Oct.
3
Percutaneous Coronary Intervention in Transcatheter Aortic Valve Implantation Patients: Overview and Practical Management.

本文引用的文献

1
Coronary Access After TAVR.经 TAVR 后的冠状动脉通路。
JACC Cardiovasc Interv. 2020 Mar 23;13(6):693-705. doi: 10.1016/j.jcin.2020.01.216.
2
Interaction Between Self-Expanding Transcatheter Heart Valves and Coronary Ostia: An Angiographically Based Analysis of the Evolut R/Pro Valve System.自膨式经导管心脏瓣膜与冠状动脉开口的相互作用:基于血管造影的 Evolut R/Pro 瓣膜系统分析。
J Invasive Cardiol. 2020 Apr;32(4):123-128. doi: 10.25270/jic/19.00455. Epub 2020 Mar 11.
3
Clinical and Technical Characteristics of Coronary Angiography and Percutaneous Coronary Interventions Performed before and after Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve.
经导管主动脉瓣植入术患者的经皮冠状动脉介入治疗:概述与实际管理
Front Cardiovasc Med. 2021 May 4;8:653768. doi: 10.3389/fcvm.2021.653768. eCollection 2021.
经皮球囊扩张式主动脉瓣置换术前后行冠状动脉造影和经皮冠状动脉介入治疗的临床和技术特点。
J Interv Cardiol. 2019 Aug 8;2019:3579671. doi: 10.1155/2019/3579671. eCollection 2019.
4
Impact of Initial Evolut Transcatheter Aortic Valve Replacement Deployment Orientation on Final Valve Orientation and Coronary Reaccess.初始Evolut经导管主动脉瓣置换术植入方向对最终瓣膜方向及冠状动脉再入路的影响
Circ Cardiovasc Interv. 2019 Jul;12(7):e008044. doi: 10.1161/CIRCINTERVENTIONS.119.008044. Epub 2019 Jul 5.
5
Incidence, Technical Safety, and Feasibility of Coronary Angiography and Intervention Following Self-expanding Transcatheter Aortic Valve Replacement.自膨胀经导管主动脉瓣置换术后冠状动脉造影及介入治疗的发生率、技术安全性和可行性
Cardiovasc Revasc Med. 2019 May;20(5):371-375. doi: 10.1016/j.carrev.2019.01.026. Epub 2019 Feb 14.
6
'Ten commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南的“十诫”
Eur Heart J. 2019 Jan 7;40(2):79-80. doi: 10.1093/eurheartj/ehy855.
7
Transcatheter Valve Neo-Commissural Overlap With Coronary Orifices After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后经导管瓣膜新交界与冠状动脉口的重叠
Circ Cardiovasc Interv. 2018 Oct;11(10):e007263. doi: 10.1161/CIRCINTERVENTIONS.118.007263.
8
Commissural Alignment of Bioprosthetic Aortic Valve and Native Aortic Valve Following Surgical and Transcatheter Aortic Valve Replacement and its Impact on Valvular Function and Coronary Filling.生物瓣主动脉瓣与自体主动脉瓣在外科和经导管主动脉瓣置换术后的交界对位及其对瓣叶功能和冠状动脉充盈的影响。
JACC Cardiovasc Interv. 2018 Sep 10;11(17):1733-1743. doi: 10.1016/j.jcin.2018.05.043. Epub 2018 Aug 15.
9
Transcatheter aortic valve implantation: don't forget the coronary arteries!经导管主动脉瓣植入术:勿忘冠状动脉!
EuroIntervention. 2018 Jun 20;14(2):147-149. doi: 10.4244/EIJV14I2A24.
10
Coronary Angiography and Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后的冠状动脉造影和经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Mar 27;71(12):1360-1378. doi: 10.1016/j.jacc.2018.01.057.